Weight-loss medication Tirzepatide (Mounjaro®)

Posted on:

A phased rollout is taking place to make weight-loss medication Tirzepatide (Mounjaro®) available to NHS Patients.

Once it is released in our locality, The Waterfield Practice will be contacting eligible patients in order of priority to offer them the treatment.

Eligibility:

Patients with a body mass index (BMI) of 40 or more, in addition to four of these five weight-related conditions:

  • Type 2 Diabetes
  • High Blood Pressure
  • Heart disease
  • Severe obstructive sleep apnoea
  • Abnormal blood fats

Those who are eligible will be contacted by the surgery.

We ask that patients do not contact us to request this treatment.